Regatta Research & Money Management’s AstraZeneca AZN Stock Holding History

Regatta Research & Money Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.1K	Buy	+160	New	+$30.1K	0.03%	344

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Aviva London, United Kingdom $67.9B AUM 39.2% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Regatta Research & Money Management's AZN Position: Q2 2026 in Review

Regatta Research & Money Management opened a new position in AstraZeneca (AZN) in Q2 2026: 160 shares worth $30.1K. The stake represents 0.03% of the portfolio and ranks #344 among its holdings.

1,183 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Regatta Research & Money Management held 160 shares of AstraZeneca worth $30.1K as of Q2 2026.
AstraZeneca was a new Regatta Research & Money Management position in Q2 2026.
AstraZeneca made up 0.03% of Regatta Research & Money Management's portfolio in Q2 2026, its #344 holding.
1,183 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Regatta Research & Money Management's 13F filing for Q2 2026, filed 12 Aug 2026.